Additionally, we observed significant expression of CLDN6, CES1, SOST, SPRR2A, MYBPH, CGB5, and KRT1 in the high-risk group, suggesting their potential involvement as cancer-promoting genes in BLCA development. Here, SOST is linked to bladder transitional cell carcinoma.